Nanoscope Technologies LLC
Bedford, TX
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 1312 Brown Trail Ste A, Bedford, TX 76022, USA
- Website
- nanoscopetech.com
- Founded
- 2009
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| The Regents Of The University Of Colorado | R01EY035092 | $104,646 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Human Cell Co | Naperville, IL | — |
| Fondation Voir Et Entendre | Paris, IDF | 541990 All Other Professional, Scientific, and Technical Services |
| Administration | Pasadena, CA | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Retinal Care Inc. | Edmond, OK | — |
| Translational Imaging Innovations Inc. | Hickory, NC | 513210 Software Publishers |
About the company
Nanoscope Technologies LLC is a for-profit limited liability company that specializes in developing innovative therapies for vision restoration and eye disease treatment. Registered to receive federal awards since July 2, 2009, the company focuses on cutting-edge research in ophthalmology, particularly in the areas of gene therapy and sonogenetic stimulation. Nanoscope Technologies has secured multiple federal grant awards from the National Eye Institute (NEI) to advance its groundbreaking work in addressing retinal degenerative diseases and glaucoma.
The company's federal grant portfolio includes several significant projects aimed at revolutionizing treatments for eye disorders. One major initiative involves the development of a non-invasive "sonogenetic" therapy to restore vision in patients with retinitis pigmentosa, supported by a $785,380 Cooperative Agreement grant under the NEI's Vision Research program. This project utilizes ultrasound stimulation of engineered mechanosensitive channels in retinal ganglion cells to achieve vision restoration in animal models. Another key project focuses on creating a pressure-modulating gene therapy for glaucoma treatment, using engineered mechanosensitive channels to improve aqueous humor drainage in the eye. Additionally, Nanoscope Technologies is working on targeted nano-enhanced optical delivery of opsin for dry age-related macular degeneration (AMD) therapy. These grants, all awarded by the National Eye Institute, demonstrate the company's commitment to developing innovative, long-lasting treatments for various eye conditions that could significantly improve the lives of millions of Americans affected by vision loss and eye diseases.
Quick answers
Is Nanoscope Technologies LLC registered in SAM.gov?
Yes. Nanoscope Technologies LLC's SAM.gov registration is active through November 12, 2026.
What is Nanoscope Technologies LLC's CAGE code?
Nanoscope Technologies LLC's CAGE code is 5KA02, and its Unique Entity ID (UEI) is H6DNZXT5MMT1.
What is Nanoscope Technologies LLC's most recent federal award?
Nanoscope Technologies LLC's most recent federal grant award is Sonogenetic restoration of vision for retinitis pigmentosa - retinitis pigmentosa (RP) often results in legal blindness… (U01EY035026), from National Eye Institute (NIH), on May 1, 2024.
On GovTribe
See Nanoscope Technologies LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors